Background: Hepatocellular adenomas (HCAs) are rare benign liver tumors. Guidelines recommend continued surveillance of patients diagnosed with HCAs, but these guidelines are mainly based on small studies or expert opinion. Purpose: To analyze the long-term evolution of HCAs, including solitary and multiple lesions, and to identify predictive features of progression with MRI. Materials and Methods: In a retrospective study, patients diagnosed with pathologically proven solitary or multiple HCAs between January 2004 and December 2015 were included; b-catenin–mutated HCAs and HCAs with foci of malignancy were considered to be at risk for progression. MRI examinations were analyzed, and tumor evolution was evaluated by using Response Evaluation Criteria in Solid Tumors, version 1.1. Student t, Mann-Whitney, x2, Fisher exact, and McNemar tests were used, as appropriate. Results: In total, 118 patients (mean age, 40 years 6 10 [standard deviation]; 108 women) were evaluated, including 41 with a solitary HCA (mean age, 40 years 6 14; 36 women) and 77 with multiple HCAs (mean age, 40 years 6 10; 72 women). At a median follow-up of 5 years, 37 of 41 (90%) patients with a solitary HCA and 55 of 77 (71%) patients with multiple HCAs showed stable or regressive disease. After resection of solitary HCAs, new lesions appeared in only two of 29 (7%) patients, both of whom had HCAs at risk of progression. In patients with multiple HCAs, hepatocyte nuclear factor 1a–inactivated HCAs showed a higher rate of progression compared with inflammatory HCAs (11 of 26 [42%] vs seven of 37 [19%], P = .04) despite lower use (28 of 32 patients [88%] vs 45 of 45 patients [100%]; P = .03) and shorter duration (mean, 12.0 years 6 7.5 vs 19.2 years 6 9.2; P = .001) of oral contraceptive intake. Conclusion: Long-term MRI follow-up showed that 78% of hepatocellular adenomas had long-term stability or regression. After resection of solitary hepatocellular adenomas, new lesions occurred only in hepatocellular adenomas at risk of progression. Patients with multiple hepatocellular adenomas were more likely to show progressive disease, with hepatic nuclear factor 1a–inactivated hepatocellular adenomas being the most common subtype showing progression.

Vernuccio F., Ronot M., Burgio M.D., Cauchy F., Choudhury K.R., Dokmak S., et al. (2020). Long-term evolution of hepatocellular adenomas at MRI follow-up. RADIOLOGY, 295(2), 361-372 [10.1148/radiol.2020191790].

Long-term evolution of hepatocellular adenomas at MRI follow-up

Vernuccio F.
;
2020-01-01

Abstract

Background: Hepatocellular adenomas (HCAs) are rare benign liver tumors. Guidelines recommend continued surveillance of patients diagnosed with HCAs, but these guidelines are mainly based on small studies or expert opinion. Purpose: To analyze the long-term evolution of HCAs, including solitary and multiple lesions, and to identify predictive features of progression with MRI. Materials and Methods: In a retrospective study, patients diagnosed with pathologically proven solitary or multiple HCAs between January 2004 and December 2015 were included; b-catenin–mutated HCAs and HCAs with foci of malignancy were considered to be at risk for progression. MRI examinations were analyzed, and tumor evolution was evaluated by using Response Evaluation Criteria in Solid Tumors, version 1.1. Student t, Mann-Whitney, x2, Fisher exact, and McNemar tests were used, as appropriate. Results: In total, 118 patients (mean age, 40 years 6 10 [standard deviation]; 108 women) were evaluated, including 41 with a solitary HCA (mean age, 40 years 6 14; 36 women) and 77 with multiple HCAs (mean age, 40 years 6 10; 72 women). At a median follow-up of 5 years, 37 of 41 (90%) patients with a solitary HCA and 55 of 77 (71%) patients with multiple HCAs showed stable or regressive disease. After resection of solitary HCAs, new lesions appeared in only two of 29 (7%) patients, both of whom had HCAs at risk of progression. In patients with multiple HCAs, hepatocyte nuclear factor 1a–inactivated HCAs showed a higher rate of progression compared with inflammatory HCAs (11 of 26 [42%] vs seven of 37 [19%], P = .04) despite lower use (28 of 32 patients [88%] vs 45 of 45 patients [100%]; P = .03) and shorter duration (mean, 12.0 years 6 7.5 vs 19.2 years 6 9.2; P = .001) of oral contraceptive intake. Conclusion: Long-term MRI follow-up showed that 78% of hepatocellular adenomas had long-term stability or regression. After resection of solitary hepatocellular adenomas, new lesions occurred only in hepatocellular adenomas at risk of progression. Patients with multiple hepatocellular adenomas were more likely to show progressive disease, with hepatic nuclear factor 1a–inactivated hepatocellular adenomas being the most common subtype showing progression.
Vernuccio F., Ronot M., Burgio M.D., Cauchy F., Choudhury K.R., Dokmak S., et al. (2020). Long-term evolution of hepatocellular adenomas at MRI follow-up. RADIOLOGY, 295(2), 361-372 [10.1148/radiol.2020191790].
File in questo prodotto:
File Dimensione Formato  
radiol.2020191790-2.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 984.99 kB
Formato Adobe PDF
984.99 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/420493
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
social impact